3D Bioprinting: Ethical Aspects and the Big Picture – Presented by Anna Pacholczyk, Centre for Ethics in Medicine, University of Bristol at the 3D Bioprinting Conference which takes place on Jan 31, 2017 at MECC Maastricht in The Netherlands.
Advances in 3D bioprinting raise ethical, social, legal and regulatory issues. This presentation outlines the contribution of ethical enquiry to considering those issues, gives a snapshot of approaches to ethical assessment and applies an ethical framework (NEST-Ethics) to guide examination of some issues raised by the development in bioprinting science and technology. While ethics and governance related to (for example) stem cell sourcing, ownership, access and justice require attention, we need to also remember about the ‘big picture’ and soft impacts of 3D printing – it is the latter that are going to create long-term culture changing impacts of 3D bioprinting.
About Anna Pacholczyk
Senior Teaching Associate in Biomedical Ethics and Law at the University of Bristol. She considers ELSI of innovations in medicine and scientific progress, including DBS, bioprinting & pharmacology. She has particular expertise in philosophical bioethics methods and is interested in developing funding proposals and collaborations with science and industry colleagues.
About Centre for Ethics in Medicine, University of Bristol
The Centre for Ethics in Medicine is a multidisciplinary centre for research and teaching in health care ethics and law. With lawyers, bioethicists and healthcare professionals at its core, it has strong links to innovative surgery, clinical and qualitative research as well as philosophy and law departments.